Company Overview and News

 
Closing Bell: Sensex ends rangebound session higher; hotels, jewellery, realty stocks rally

2018-04-17 moneycontrol
3:30 pm Market Closing: Benchmark indices managed to end near day's high after volatility throughout the session.
Upvote Downvote

 
Bharat-22 ETF follow-on offer could be worth ₹10,000 cr

2018-04-17 thehindubusinessline
The Finance Ministry may come out with a ₹10,000-crore follow-on fund offer of the Bharat-22 exchange traded fund (ETF) as it looks to dilute stake in Coal India to meet the minimum public holding norm.
Upvote Downvote

 
Market Live: Nifty holds 10,500 amid consolidation; corporate earnings eyed

2018-04-17 moneycontrol
1:58 pm Car Price Hike: Toyota Kirloskar Motor (TKM) is planning to increase vehicle prices from next month in order to partially offset rise in input costs.
Upvote Downvote

 
Sensex turns rangebound; Nifty above 10,500 

2018-04-17 freepressjournal.in
Mumbai: The BSE Sensex pared morning gains to turn rangebound amid losses on IT, pharma and auto counters, and mixed Asian cues. The 30-share index was trading higher at 34,317.73 at 1200 Hrs, with a gain of 12.30 points, or 0.04 per cent. The broader Nifty50 index was also trading above 10,500-level at 10,526.10, up 2.25 points or 0.02 per cent.
Upvote Downvote

 
Sensex extends gains on normal monsoon forecast

2018-04-17 freepressjournal.in
Mumbai: Extending its rising streak for the ninth session, the benchmark BSE Sensex advanced nearly 100 points in opening trade today, after forecast of a normal monsoon for the year.
Upvote Downvote

 
Cabinet approves framework for Coal Bed Methane extraction by Coal India

2018-04-11 thehindubusinessline
Coal India and its subsidiaries will now be able to extract Coal Bed Methane from its mines without seeking approvals under the Petroleum & Natural Gas Rules 1959 (PNG Rules, 1959).
Upvote Downvote

 
Govt nod for natural gas exploration in areas allotted to CIL

2018-04-11 livemint
Mumbai/Bengaluru: In what will help expand India’s coal bed methane (CBM) sector, the cabinet committee on economic affairs (CCEA) on Wednesday approved exploration and production from areas allotted to state-run Coal India Ltd (CIL)—the world’s largest coal miner—and its subsidiaries.
Upvote Downvote

 
Relaxation in CBM rule bodes well for Coal India

2018-04-11 thehindubusinessline
The Union Cabinet on Wednesday relaxed rules for Coal India for extraction of natural gas lying below coal seams in its blocks in a bid to quickly boost production.
Upvote Downvote

 
Cabinet approves framework for Coal Bed Methane extraction by Coal India

2018-04-11 thehindubusinessline
Coal India and its subsidiaries will now be able to extract Coal Bed Methane from its mines without seeking approvals under the Petroleum & Natural Gas Rules 1959 (PNG Rules, 1959).
Upvote Downvote

 
Coal India Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Closing Bell: Global cues lift Sensex 92 pts, Nifty above 10,400; Axis Bank up 5%

2018-04-10 moneycontrol
3:30 pm Market Closing: The market closed higher for fourth consecutive session on Tuesday, with the Sensex rising 91.71 points to 33,880.25 and the Nifty gaining 22.90 points at 10,402.30.
Upvote Downvote

 
Finmin may write to Sebi for relaxing minimum public float norms for PSUs

2018-04-10 freepressjournal.in
New Delhi : The finance ministry is considering writing to markets regulator Sebi seeking relaxation for certain state-owned firms from meeting the minimum 25 per cent public shareholding norm.
Upvote Downvote

 
Coal India awaits CCEA clearance to start extraction of CBM

2018-04-08 moneycontrol
The Cabinet may soon take a call on whether a fresh lease is required by state-owned Coal India for extracting coal bed methane (CBM) which remains untapped in want of clarity, a top official today said.
Upvote Downvote

 
Closing Bell: Sensex, Nifty end flat amid US-China trade war woes; Lupin, Titan rally

2018-04-06 moneycontrol
3:30 pm Market Closing: Benchmark indices closed flat on Friday as investors await March quarter earnings season that will be kicked off by Infosys next week.
Upvote Downvote

 
Market Live: Nifty holds 10,300 amid consolidation; Titan, BPCL, HPCL top gainers

2018-04-06 moneycontrol
2:48 pm Buzzing: Shares of Ballarpur Industries surged 12 percent intraday as the company is going to sell entire assets of its Malaysian unit, Sabah Forest Industries Sdn Bhd.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...